High-molecular-weight hydroxyethyl starches (hetastarches) can cause acquired type I von Willebrand's disease. 1 A case has also occurred after treatment with medium-molecular-weight hydroxyethyl ...
There are currently 4 FDA-approved hydroxyethyl starch products on the market. The Food and Drug Administration (FDA) is requiring that the Boxed Warning for hydroxyethyl starch products be amended to ...
In an analysis of studies that examined critically ill patients requiring an increase in blood fluid volume, intravenous use of the fluid hydroxyethyl starch, compared with other resuscitation ...
In 2012, the results of the Crystalloid versus Hydroxyethyl Starch Trial (CHEST) were published. 1 CHEST was an investigator-initiated, randomized, controlled trial in which 6% hydroxyethyl starch ...
The FDA is recommending that hydroxyethyl starch (HES) solutions should not be used in critically ill adult patients, including those with sepsis and those admitted to the ICU. RELATED: Bleeding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results